Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by bionicjoeon Apr 28, 2019 4:51pm

91 Views

Post# 29681211

RE:RE:RE:RE:RE:RE:RE:RE:Phase II ACT-NMIBC study

Haven't you been reading this board? A 230% upturn in the sp is the least this board's posters expected from the 12 month results of patient 5 & 6. Your 30% is peanuts when considering the monumental scope of the results. Are you suggesting that it's going to be a while before the sp reaches a buck?

Bullboard Posts

How a junior advances one of the largest undeveloped diamond projects